Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation
- Generic Name
- Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation
Overview
No overview information available.
Background
No background information available.
Indication
用于慢性阻塞性肺病（慢阻肺）患者（COPD）的维持治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
H20190062 | 气雾剂 | N/A | 每瓶56揿,每揿含布地奈德160μg、格隆铵7.2μg和富马酸福莫特罗4.8μg | Chemical Drug | Approved | 2019/12/18 | Import | ||
国药准字HJ20190063 | 气雾剂 | N/A | 每瓶120揿，每揿含布地奈德160μg、格隆铵7.2μg和富马酸福莫特罗4.8μg | Chemical Drug | Approved | 2024/09/02 | Import | ||
H20190063 | 气雾剂 | N/A | 每瓶120揿,每揿含布地奈德160μg、格隆铵7.2μg和富马酸福莫特罗4.8μg | Chemical Drug | Approved | 2019/12/18 | Import |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug
© Copyright 2025. All Rights Reserved by MedPath